I was thinking about buying AMGN or BIIB but GILD has an amazing cure for Hep C, worlwide patients 170 million. Its going to beat the competition from Merck because its regimen is simpler to use especially when Giliad comes up with the combination pill later this year.
2 million in U.S. and 2 million in Japan will pay top $ to get cured. They will charge rest of the world a sliding scale and still make money. $84,000 to cure a deadly disease is a no brainer.